(Q24186532)

title

Luteal phase support for assisted reproduction cycles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

3

0 references

author name string

Michelle van der Linden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

Karen Buckingham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

Mostafa Metwally

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

Cindy Farquhar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

Jan A M Kremer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

7 July 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

page(s)

CD009154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Estradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A randomized comparison of the efficacy, side effects and patient convenience between vaginal and rectal administration of Cyclogest® when used for luteal phase support in ICSI treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Does luteal estradiol supplementation have a role in long agonist cycles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles - a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of <or=7 mm on day of egg retrieval

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Salivary and serum progesterone concentrations during two luteal support regimens used in in vitro fertilization treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone--impact of luteal estrogen: prospective, randomized study and post hoc analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Improving the luteal phase after ovarian stimulation: reviewing new options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal phase progesterone increases live birth rate after frozen embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of Crinone 8% intravaginal gel and intramuscular progesterone for luteal support in in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal support: progestogens for pregnancy protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Estradiol supplementation in intracytoplasmic sperm injection cycles with thin endometrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Duration of luteal support (DOLS) with progesterone pessaries to improve the success rates in assisted conception: study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Experience with a novel vaginal progesterone preparation in a donor oocyte program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Effect of delayed initiation of gonadotropin in luteal long protocol on in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Treatment of luteal phase defects in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression--a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Oral micronized progesterone combined with vaginal progesterone gel for luteal support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal phase support in assisted reproductive technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Human chorionic gonadotrophin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilization and embryo transfer programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal phase support in assisted reproduction cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Luteal phase support for assisted reproduction cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

Estrogen role in the luteal phase support in in vitro fertilization with embryo transfer cycles

21 January 2018

1 reference

12 December 2020

Assessment and Hormonal Treatment of the Luteal Phase of In Vitro Fertilization Cycles

1 reference

12 December 2020

The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support

1 reference

12 December 2020

The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT

1 reference

12 December 2020

Increasing the dosage of progesterone (P) supplemention from the mid-luteal phase in women not attaining a mid-luteal homogeneous hyperechogenic (HH) pattern with sonography improves pregnancy rates (PRS) following frozen embryo transfer (ET).

1 reference

12 December 2020

The luteal phase after 3 decades of IVF: what do we know?

1 reference

12 December 2020

Chorionic gonadotropin support of the luteal phase following in vitro fertilization and embryo transfer. Randomized comparison with oral progesterone in protocols using triptoreline

1 reference

12 December 2020

Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

1 reference

12 December 2020

Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women

1 reference

12 December 2020

Results' analysis of estradiol and progesterone supplementation in luteal phase vs progesterone alone in an assisted reproduction program

1 reference

12 December 2020

Effect of preovulatory progesterone administration on the endometrial maturation and implantation rate after in vitro fertilization and embryo transfer

1 reference

12 December 2020

A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program

1 reference

12 December 2020

[Luteal support in the IVF/ET programme]

1 reference

12 December 2020

GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study

1 reference

12 December 2020

Effect of high-dose estrogen in luteal phase support on live birth rates after assisted reproduction treatment cycles.

1 reference

12 December 2020

Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8) or intramuscular (Prontogest) progesterone: results of a prospective randomized study

1 reference

12 December 2020

The luteal phase after in-vitro fertilization and related procedures

1 reference

12 December 2020

Luteal rescue in in vitro fertilization-embryo transfer

1 reference

12 December 2020

Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles

1 reference

12 December 2020

Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles

1 reference

12 December 2020

A study of two different routes of administration of micronized progesterone in assisted reproduction

1 reference

12 December 2020

The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone

1 reference

12 December 2020

Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer

1 reference

12 December 2020

Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection.

1 reference

12 December 2020

Support of the luteal phase in in vitro fertilization programs: Results of a controlled trial with intramuscular proluton

1 reference

12 December 2020

The effect of luteal support with human chorionic gonadotrophin or progesterone on the daily progesterone profile after different types of ovarian stimulation

1 reference

12 December 2020

Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles

1 reference

12 December 2020

Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer. A comparative randomized study

1 reference

12 December 2020

A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation

1 reference

12 December 2020

Establishing full-term human pregnancies using cleaving embryos grown in vitro

1 reference

12 December 2020

The effect of dydrogesterone supplementation in an IVF programme

1 reference

12 December 2020

Evaluation of luteal support therapy in a randomized controlled study within a gamete intrafallopian transfer program.

1 reference

12 December 2020

Luteal-phase endocrinology.

1 reference

12 December 2020

Luteal phase support does not improve the clinical pregnancy rate of natural cycle frozen-thawed embryo transfer: a retrospective analysis

1 reference

12 December 2020

Intramuscular versus vaginal progesterone in assisted reproduction: a comparative study.

1 reference

12 December 2020

Early pregnancy support in an in vitro fertilization program: does human chorionic gonadotropin reduce the miscarriage rate?

1 reference

12 December 2020

Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles

1 reference

12 December 2020

Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone

1 reference

12 December 2020

[Intramuscular vs vaginal progesterone for luteal support in cycles of in vitro fertilization]

1 reference

12 December 2020

Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles

1 reference

12 December 2020

Vaginal progesterone as luteal phase support in an IVF/GIFT programme

1 reference

12 December 2020

Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer

1 reference

12 December 2020

Placental protein 14 secretion during in vitro fertilization cycles with and without human chorionic gonadotropin for luteal support

1 reference

12 December 2020

A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer

1 reference

12 December 2020

The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women

1 reference

12 December 2020

The effect of human chorionic gonadotropin and pregnancy on the circulating level of relaxin

1 reference

12 December 2020

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial

1 reference

12 December 2020

Luteal phase support for in vitro fertilization-embryo transfer--present and future methods to improve successful implantation.

1 reference

12 December 2020

Elevation of serum progesterone with oral micronized progesterone after in vitro fertilization. A randomized, controlled trial

1 reference

12 December 2020

Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study

1 reference

12 December 2020

A comparison of the effects of three different luteal phase support protocols on in vitro fertilization outcomes: a randomized clinical trial

1 reference

12 December 2020

[Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone]

1 reference

12 December 2020

Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins

1 reference

12 December 2020

Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin

1 reference

12 December 2020

Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles

1 reference

12 December 2020

A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer

1 reference

12 December 2020

Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study

1 reference

12 December 2020

A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route

1 reference

12 December 2020

The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study

1 reference

12 December 2020

A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles

1 reference

12 December 2020

Efficacy of oral micronized progesterone when applied via vaginal route.

1 reference

12 December 2020

The effect of progesterone supplementation around the time of oocyte recovery in patients superovulated for in vitro fertilization

1 reference

12 December 2020

The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles

1 reference

12 December 2020

Luteal phase support with 17alpha-hydroxyprogesterone versus unsupported cycles in in vitro fertilization: a comparative randomized study

1 reference

12 December 2020

Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial

1 reference

12 December 2020

Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study

1 reference

12 December 2020

Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone

1 reference

12 December 2020

Luteal support with both estradiol and progesterone after clomiphene citrate stimulation for in vitro fertilization.

1 reference

12 December 2020

Improved implantation and live delivered pregnancy rates following transfer of embryos derived from donor oocytes by single injection of leuprolide in mid-luteal phase.

1 reference

12 December 2020

Role of luteal phase support on gonadotropin ovulation induction cycles in patients with polycystic ovary syndrome

1 reference

12 December 2020

Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial

1 reference

12 December 2020

Estradiol supplementation during the luteal phase of in vitro fertilization cycles: a prospective randomised study

1 reference

12 December 2020

17-alpha-Hydroxyprogesterone caproate and natural progesterone in assisted reproduction: a comparative study

1 reference

12 December 2020

Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles

1 reference

12 December 2020

Early luteal serum progesterone concentrations are higher in pregnancy cycles

1 reference

12 December 2020

[Luteal support after administration of an LHRH analog for in vitro fertilization. Superiority of vaginal progesterone in comparison with oral progesterone]

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin

1 reference

12 December 2020

Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial

1 reference

12 December 2020

[In vitro maturation of oocytes: a novel method of treatment of patients with polycystic ovarian syndrome undergoing in vitro fertilization]

1 reference

12 December 2020

Luteal phase support in IVF patients at low risk for OHSS: progesterone vs. progesterone plus hCG. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD009154.PUB3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6461197&resulttype=core&format=json

13 May 2020

1 reference